sameAs
Expression of serotonin receptors 2B and 4 in human prostate cancer tissue and effects of their antagonists on prostate cancer cell linesExpression and localisation of aquaporin water channels in human urothelium in situ and in vitroPhase 1 and 2 studies demonstrate the safety and efficacy of intraprostatic injection of PRX302 for the targeted treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasiaMetabolism of kidney cancer: from the lab to clinical practiceThe relationship between nutrition and prostate cancer: is more always better?Genetic susceptibility to distinct bladder cancer subphenotypesPreoperative Membranous Urethral Length Measurement and Continence Recovery Following Radical Prostatectomy: A Systematic Review and Meta-analysisLong-term Impact of Mode of Delivery on Stress Urinary Incontinence and Urgency Urinary Incontinence: A Systematic Review and Meta-analysisSurgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysisCardiovascular Safety of β3-adrenoceptor Agonists for the Treatment of Patients with Overactive Bladder SyndromeSystematic review of complications of prostate biopsyThe mutational landscape of prostate cancerPatient-reported outcomes in randomised controlled trials of prostate cancer: methodological quality and impact on clinical decision makingOverdiagnosis and overtreatment of prostate cancerThe Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research.Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08).DNA Repair in Prostate Cancer: Biology and Clinical ImplicationsSafety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulationA candidate gene approach within the susceptibility region PCaP on 1q42.2-43 excludes deleterious mutations of the PCTA-1 gene to be responsible for hereditary prostate cancerDetection of the 67-kD laminin receptor in prostate cancer biopsies as a predictor of recurrence after radical prostatectomyThe vicious cycling: bicycling related urogenital disordersThe effect of parenteral estrogen versus orchiectomy on blood coagulation and fibrinolysis in prostatic cancer patientsProstate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancerPenile transplantation?A preliminary report of penile transplantationPositive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomyPolymorphisms in the H19 gene and the risk of bladder cancerEAU guidelines on vesicoureteral reflux in childrenGuidelines on male sexual dysfunction: erectile dysfunction and premature ejaculationRe: Weilie Hu, Jun Lu, Lichao Zhang, et al. A preliminary report of penile transplantation. Eur urol 2006;50:851-3Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective phase 2 trialsNephroptosis and nephropexy--hung up on the past?Cyproterone acetate in the treatment of advanced prostatic cancer: retrospective analysis of liver toxicity in the long-term follow-up of 89 patientsHyperbaric oxygen therapy for control of intractable cyclophosphamide-induced hemorrhagic cystitisResearch in 'prostatitis syndromes': the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalitiesNephrogenic adenoma in a patient with chronic renal failure associated with intravesical treatment with thiotepaProgestogens in prostatic cancerPharmacological management of incontinenceUrolithiasis and the protease inhibitor indinavir
P1433
Q24304160-633F9484-DBB9-4935-937C-1B0130C81F78Q24329081-3F7FDA75-40AE-4589-911E-882988D91D2EQ24594742-68F179CB-076D-4209-ABE4-39220F81832BQ24600512-CCA272A1-D072-4EC3-B703-13E85C0FE6F5Q24604956-053EB72E-341C-4505-8E11-0283B080CE37Q24624419-5795D93D-702C-4274-8892-E4D63F8533F3Q26743424-F91E54B3-175A-49DD-AB91-0A64D291132EQ26766188-28E0691F-6F39-4F53-9874-8A16E75E46AEQ26772137-351256D5-5962-4A26-A55F-136B470EC9DEQ26783965-7DAD1974-B561-415F-9D81-ACAEA677F684Q26822966-08D2E575-DE79-42C1-961B-B96C01B7E70AQ26851631-342E8CC0-491D-4A2A-8E37-25FB242011D3Q26852751-D6D400CC-2FBB-4812-96B4-01ED1E55B739Q26859596-5FF63DBF-E9E9-4FE8-BD2B-84B3B268C54BQ27311513-08F59E14-1A2B-411C-91C9-662CAE217812Q27852197-3F1481AA-9050-4DDE-BAFE-E8BD9D0CE876Q28079127-7B8FD22F-7136-4052-B4E7-3B5290C6DDDDQ28200396-0A1CB77B-9778-491A-AEB1-D9C75B1D8265Q28202063-DB71904E-40C7-4565-B4D9-8364884A959BQ28213097-114C7874-9FD9-49A4-A594-F2EAC190576CQ28235464-5667B218-9FD7-442B-A4A9-69E076D8C4B1Q28244079-330DF62D-4CE8-455E-A9BC-3A34755728EFQ28254022-18654CF5-30D2-4ECC-8F6D-8090CDB89A91Q28255916-2D17308F-3B35-4ABB-9110-659DD13B9587Q28259809-536DDD69-8609-422D-B75E-1D269D0AC65EQ28259820-F9AA024B-5EFE-4947-ACEB-E89A42257295Q28261573-D7993230-9582-4C54-82A2-06C0812541E0Q28268067-0D8CA1B5-23A1-42CE-B4FA-3BC247B3BBA6Q28268782-21EFCE61-FAE8-46CA-9774-14FD8B8A1FB2Q28274474-BC70AADB-12AF-4B55-843F-F0A8732F3BF3Q28275544-C3AB2B37-C2C1-405C-BA9C-D23ED2FA2B31Q28280571-54CF9ABF-5F0F-4381-A540-E3A26F5DF8B7Q28281758-BBA69D35-08C9-4BC4-BCDA-7A8F08F0508CQ28300084-4EACF913-4DA1-4D1A-B690-3F3F213BBBA0Q28317841-1C9FA2FB-73D4-48C8-A2B2-3A734F5E31EEQ28327832-CCCE75AB-191B-468A-8A3A-92D63D566303Q28329230-BA2B96BA-41AD-4960-8E1B-2EEFA9B9AF4CQ28332488-26C55616-F2E0-4EA0-9012-3528A00E9358Q28368323-DADD97CA-2591-4322-98EB-D763D484B37FQ28371146-2E61E65A-917D-40CF-8CD9-016A37C2C760
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
wetenschappelijk tijdschrift van Elsevier
@nl
рецензований науковий журнал
@uk
英语期刊
@zh
name
European Urology
@ast
European Urology
@da
European Urology
@de
European Urology
@en
European Urology
@es
European Urology
@fi
European Urology
@fr
European Urology
@it
European Urology
@nb
European Urology
@nl
type
label
European Urology
@ast
European Urology
@da
European Urology
@de
European Urology
@en
European Urology
@es
European Urology
@fi
European Urology
@fr
European Urology
@it
European Urology
@nb
European Urology
@nl
prefLabel
European Urology
@ast
European Urology
@da
European Urology
@de
European Urology
@en
European Urology
@es
European Urology
@fi
European Urology
@fr
European Urology
@it
European Urology
@nb
European Urology
@nl
P236
P31
P243
P3181
P1055
P1058
P1156
P1159
P1160
Eur. Urol.
P123
P1250
P1277
P1476
European Urology
@en
P236
P243
P407
P495
P571
1975-01-01T00:00:00Z